NLRX1 limits inflammatory neurodegeneration in the anterior visual pathway
Abstract Chronic innate immune activation in the central nervous system (CNS) significantly contributes to neurodegeneration in progressive multiple sclerosis (MS). Using multiple experimental autoimmune encephalomyelitis (EAE) models, we discovered that NLRX1 protects neurons in the anterior visual...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-01-01
|
| Series: | Journal of Neuroinflammation |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12974-025-03339-0 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832571425832042496 |
|---|---|
| author | Alexander J. Gill Matthew D. Smith Danny Galleguillos Thomas Garton Jackson W. Mace Sachin P. Gadani Swati Kumar Aayush Pokharel Krista Solem Saahith Potluri Omar Hussein Giuliana Sardi Rogines Arihant Singh Annatje Clark Peter A. Calabresi Marjan Gharagozloo |
| author_facet | Alexander J. Gill Matthew D. Smith Danny Galleguillos Thomas Garton Jackson W. Mace Sachin P. Gadani Swati Kumar Aayush Pokharel Krista Solem Saahith Potluri Omar Hussein Giuliana Sardi Rogines Arihant Singh Annatje Clark Peter A. Calabresi Marjan Gharagozloo |
| author_sort | Alexander J. Gill |
| collection | DOAJ |
| description | Abstract Chronic innate immune activation in the central nervous system (CNS) significantly contributes to neurodegeneration in progressive multiple sclerosis (MS). Using multiple experimental autoimmune encephalomyelitis (EAE) models, we discovered that NLRX1 protects neurons in the anterior visual pathway from inflammatory neurodegeneration. We quantified retinal ganglion cell (RGC) density and optic nerve axonal degeneration, gliosis, and T-cell infiltration in Nlrx1 −/− and wild-type (WT) EAE mice and found increased RGC loss and axonal injury in Nlrx1 −/− mice compared to WT mice in both active immunization EAE and spontaneous opticospinal encephalomyelitis (OSE) models. To minimize the effects of Nlrx1 −/− on peripheral lymphocyte priming during EAE, we performed adoptive transfer experiments, in which activated myelin-specific T cells were transferred into lymphocyte-deficient Rag −/− or Nlrx1 −/− Rag −/− mice. In this model, we found more severe microgliosis and astrogliosis in the optic nerve of Nlrx1 −/− Rag −/− mice compared to Rag −/− mice, suggesting a regulatory role of NLRX1 in innate immune cells. Transcriptome analysis in primary astrocytes activated with LPS and IFNγ demonstrated that NLRX1 suppresses NF-κB activation and regulates mitochondrial oxidative phosphorylation in inflammatory reactive astrocytes. The novel pharmacologic NLRX1 activators NX-13 and LABP-66 decreased LPS-mediated gene expression of inflammatory cytokines and chemokines in mixed glial cultures. Moreover, treating EAE mice with oral LABP-66, compared to vehicle, after the onset of paralysis resulted in less anterior visual pathway neurodegeneration. These data suggest that pharmacologic NLRX1 activators have the potential to limit inflammatory neurodegeneration. This study highlights that NLRX1 could serve as a promising target for neuroprotection in progressive MS and other neurodegenerative diseases. Further studies are needed to better understand the cell-specific mechanisms underlying the neuroprotective role of NLRX1 in response to inflammation in the CNS. |
| format | Article |
| id | doaj-art-182dda923e9c4c6a9ddddcdc9c90c5f2 |
| institution | Kabale University |
| issn | 1742-2094 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | BMC |
| record_format | Article |
| series | Journal of Neuroinflammation |
| spelling | doaj-art-182dda923e9c4c6a9ddddcdc9c90c5f22025-02-02T12:34:58ZengBMCJournal of Neuroinflammation1742-20942025-01-0122112210.1186/s12974-025-03339-0NLRX1 limits inflammatory neurodegeneration in the anterior visual pathwayAlexander J. Gill0Matthew D. Smith1Danny Galleguillos2Thomas Garton3Jackson W. Mace4Sachin P. Gadani5Swati Kumar6Aayush Pokharel7Krista Solem8Saahith Potluri9Omar Hussein10Giuliana Sardi Rogines11Arihant Singh12Annatje Clark13Peter A. Calabresi14Marjan Gharagozloo15Department of Neurology, Division of Neuroimmunology, School of Medicine, Johns Hopkins UniversityDepartment of Neurology, Division of Neuroimmunology, School of Medicine, Johns Hopkins UniversityDepartment of Neurology, Division of Neuroimmunology, School of Medicine, Johns Hopkins UniversityDepartment of Neurology, Division of Neuroimmunology, School of Medicine, Johns Hopkins UniversityDepartment of Neurology, Division of Neuroimmunology, School of Medicine, Johns Hopkins UniversityDepartment of Neurology, Division of Neuroimmunology, School of Medicine, Johns Hopkins UniversityDepartment of Neurology, Division of Neuroimmunology, School of Medicine, Johns Hopkins UniversityDepartment of Neurology, Division of Neuroimmunology, School of Medicine, Johns Hopkins UniversityDepartment of Neurology, Division of Neuroimmunology, School of Medicine, Johns Hopkins UniversityDepartment of Neurology, Division of Neuroimmunology, School of Medicine, Johns Hopkins UniversityDepartment of Neurology, Division of Neuroimmunology, School of Medicine, Johns Hopkins UniversityDepartment of Neurology, Division of Neuroimmunology, School of Medicine, Johns Hopkins UniversityDepartment of Neurology, Division of Neuroimmunology, School of Medicine, Johns Hopkins UniversityDepartment of Neurology, Division of Neuroimmunology, School of Medicine, Johns Hopkins UniversityDepartment of Neurology, Division of Neuroimmunology, School of Medicine, Johns Hopkins UniversityDepartment of Neurology, Division of Neuroimmunology, School of Medicine, Johns Hopkins UniversityAbstract Chronic innate immune activation in the central nervous system (CNS) significantly contributes to neurodegeneration in progressive multiple sclerosis (MS). Using multiple experimental autoimmune encephalomyelitis (EAE) models, we discovered that NLRX1 protects neurons in the anterior visual pathway from inflammatory neurodegeneration. We quantified retinal ganglion cell (RGC) density and optic nerve axonal degeneration, gliosis, and T-cell infiltration in Nlrx1 −/− and wild-type (WT) EAE mice and found increased RGC loss and axonal injury in Nlrx1 −/− mice compared to WT mice in both active immunization EAE and spontaneous opticospinal encephalomyelitis (OSE) models. To minimize the effects of Nlrx1 −/− on peripheral lymphocyte priming during EAE, we performed adoptive transfer experiments, in which activated myelin-specific T cells were transferred into lymphocyte-deficient Rag −/− or Nlrx1 −/− Rag −/− mice. In this model, we found more severe microgliosis and astrogliosis in the optic nerve of Nlrx1 −/− Rag −/− mice compared to Rag −/− mice, suggesting a regulatory role of NLRX1 in innate immune cells. Transcriptome analysis in primary astrocytes activated with LPS and IFNγ demonstrated that NLRX1 suppresses NF-κB activation and regulates mitochondrial oxidative phosphorylation in inflammatory reactive astrocytes. The novel pharmacologic NLRX1 activators NX-13 and LABP-66 decreased LPS-mediated gene expression of inflammatory cytokines and chemokines in mixed glial cultures. Moreover, treating EAE mice with oral LABP-66, compared to vehicle, after the onset of paralysis resulted in less anterior visual pathway neurodegeneration. These data suggest that pharmacologic NLRX1 activators have the potential to limit inflammatory neurodegeneration. This study highlights that NLRX1 could serve as a promising target for neuroprotection in progressive MS and other neurodegenerative diseases. Further studies are needed to better understand the cell-specific mechanisms underlying the neuroprotective role of NLRX1 in response to inflammation in the CNS.https://doi.org/10.1186/s12974-025-03339-0MSInnate immunityNLRX1NeurodegenerationEAERetina |
| spellingShingle | Alexander J. Gill Matthew D. Smith Danny Galleguillos Thomas Garton Jackson W. Mace Sachin P. Gadani Swati Kumar Aayush Pokharel Krista Solem Saahith Potluri Omar Hussein Giuliana Sardi Rogines Arihant Singh Annatje Clark Peter A. Calabresi Marjan Gharagozloo NLRX1 limits inflammatory neurodegeneration in the anterior visual pathway Journal of Neuroinflammation MS Innate immunity NLRX1 Neurodegeneration EAE Retina |
| title | NLRX1 limits inflammatory neurodegeneration in the anterior visual pathway |
| title_full | NLRX1 limits inflammatory neurodegeneration in the anterior visual pathway |
| title_fullStr | NLRX1 limits inflammatory neurodegeneration in the anterior visual pathway |
| title_full_unstemmed | NLRX1 limits inflammatory neurodegeneration in the anterior visual pathway |
| title_short | NLRX1 limits inflammatory neurodegeneration in the anterior visual pathway |
| title_sort | nlrx1 limits inflammatory neurodegeneration in the anterior visual pathway |
| topic | MS Innate immunity NLRX1 Neurodegeneration EAE Retina |
| url | https://doi.org/10.1186/s12974-025-03339-0 |
| work_keys_str_mv | AT alexanderjgill nlrx1limitsinflammatoryneurodegenerationintheanteriorvisualpathway AT matthewdsmith nlrx1limitsinflammatoryneurodegenerationintheanteriorvisualpathway AT dannygalleguillos nlrx1limitsinflammatoryneurodegenerationintheanteriorvisualpathway AT thomasgarton nlrx1limitsinflammatoryneurodegenerationintheanteriorvisualpathway AT jacksonwmace nlrx1limitsinflammatoryneurodegenerationintheanteriorvisualpathway AT sachinpgadani nlrx1limitsinflammatoryneurodegenerationintheanteriorvisualpathway AT swatikumar nlrx1limitsinflammatoryneurodegenerationintheanteriorvisualpathway AT aayushpokharel nlrx1limitsinflammatoryneurodegenerationintheanteriorvisualpathway AT kristasolem nlrx1limitsinflammatoryneurodegenerationintheanteriorvisualpathway AT saahithpotluri nlrx1limitsinflammatoryneurodegenerationintheanteriorvisualpathway AT omarhussein nlrx1limitsinflammatoryneurodegenerationintheanteriorvisualpathway AT giulianasardirogines nlrx1limitsinflammatoryneurodegenerationintheanteriorvisualpathway AT arihantsingh nlrx1limitsinflammatoryneurodegenerationintheanteriorvisualpathway AT annatjeclark nlrx1limitsinflammatoryneurodegenerationintheanteriorvisualpathway AT peteracalabresi nlrx1limitsinflammatoryneurodegenerationintheanteriorvisualpathway AT marjangharagozloo nlrx1limitsinflammatoryneurodegenerationintheanteriorvisualpathway |